» Authors » Frederick Sundram

Frederick Sundram

Explore the profile of Frederick Sundram including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 462
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Plank J, Chen J, Sundram F, Hoeh N, Muthukumaraswamy S, Lin J
Brain Behav . 2024 Dec; 15(1):e70249. PMID: 39740795
Introduction: Considerable evidence suggests a pathophysiological role of neuroinflammation in psychiatric disorders. Lumbar puncture and positron emission tomography (PET) show increased levels of inflammation in psychiatric disorders. However, the invasive...
2.
Ong Q, Ang C, Chee D, Lawate A, Sundram F, Dalakoti M, et al.
Artif Intell Med . 2024 Oct; 157:103004. PMID: 39454500
Objective: Recent advances in large language models (LLM) offer opportunities to automate health coaching. With zero-shot learning ability, LLMs could revolutionize health coaching by providing better accessibility, scalability, and customization....
3.
Hopkins J, Skudder E, Sundram F, Vroegop P
Australas Psychiatry . 2024 Sep; 33(1):64-75. PMID: 39298649
Objective: The aim of this study was to conduct an in-depth survey of psychiatric care provided for children and young people (CYP) in general hospital settings in New Zealand (NZ)....
4.
Murphy R, Sumner R, Godfrey K, Mabidikama A, Roberts R, Sundram F, et al.
Psychopharmacology (Berl) . 2024 Sep; 242(2):337-351. PMID: 39235512
Introduction: Enhanced creativity is often cited as an effect of microdosing (taking repeated low doses of a psychedelic drug). There have been recent efforts to validate the reported effects of...
5.
Daldegan-Bueno D, Donegan C, Forsyth A, Sumner R, Murphy R, Menkes D, et al.
Trials . 2024 Aug; 25(1):560. PMID: 39182140
Background: Major depressive disorder (MDD) poses a significant global health burden with available treatments limited by inconsistent efficacy and notable side effects. Classic psychedelics, including lysergic acid diethylamide (LSD), have...
6.
Patel S, Zhang T, Liem B, Sundram F, Roxburgh R, Barber P
N Z Med J . 2024 Jul; 137(1599):49-54. PMID: 39024584
Aims: To describe the clinical features and outcomes of patients with myelopathy and neuropathy due to recreationally inhaled nitrous oxide. Methods: We identified patients presenting with nitrous oxide-associated myelopathy from...
7.
Allen N, Jeremiah A, Murphy R, Sumner R, Forsyth A, Hoeh N, et al.
Transl Psychiatry . 2024 Apr; 14(1):191. PMID: 38622150
Microdosing psychedelic drugs at a level below the threshold to induce hallucinations is an increasingly common lifestyle practice. However, the effects of microdosing on sleep have not been previously reported....
8.
Wells A, Muthukumaraswamy A, Morunga E, Evans W, Cavadino A, Bansal M, et al.
Pilot Feasibility Stud . 2024 Feb; 10(1):29. PMID: 38347582
Background: An advanced cancer diagnosis can be associated with a significant profile of distress. Psychedelic compounds have shown clinically significant effects in the treatment of psychological distress in patients with...
9.
Chatterjee S, Mishra J, Sundram F, Roop P
Sensors (Basel) . 2024 Jan; 24(1). PMID: 38203024
Digital health applications using Artificial Intelligence (AI) are a promising opportunity to address the widening gap between available resources and mental health needs globally. Increasingly, passively acquired data from wearables...
10.
Donegan C, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, et al.
Pilot Feasibility Stud . 2023 Oct; 9(1):169. PMID: 37798662
Background: Globally, an estimated 260 million people suffer from depression [1], and there is a clear need for the development of new, alternative antidepressant therapies. In light of problems with...